medigraphic.com
SPANISH

Salud Mental

ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2004, Number 5

<< Back Next >>

Salud Mental 2004; 27 (5)

Estudio doble ciego con antidepresivo, psicoterapia breve y placebo en pacientes con depresión leve a moderada

López RJ, López BMA, Vargas TBE, Villamil SV
Full text How to cite this article

Language: Spanish
References: 24
Page: 53-61
PDF size: 203.81 Kb.


Key words:

Depression, Bellak’s psychotherapy, antidepressants, placebo.

ABSTRACT

Background: Depression is the most frequent mental disorder in the world; its overall prevalence is about 8-12%. In Mexico, it has been calculated that 8.3% of the population aged 18-64 years has suffered this disorder along their lifetime. Disregarding country or culture, depression is two to three times more frequent in women than in men, more usual among separated or divorced people, and in those who live alone or in rural areas. Although it can be present at any time, 50% of the subjects start suffering depression when they are between 20 to 50 years old, with 40 years being the average age. The etiology of depression is multifactorial because the biological, genetic and psychosocial factors which are involved release the illness or exacerbate its symptoms at a lesser or greater degree. From a psychoanalytical point of view, Freud postulated that depressed patients directed their anger towards themselves as a result of an identification with the lost object; being this the only way the “self ” has to give up the object. As a result, new psychological theories of depression came into being, together with new kinds of treatment. In the last ten years, the role of psychotherapy in the treatment of depression has been widely discussed, and it has been proposed as a part of an integral handling. Nevertheless, such a treatment depends on the severity of depression and of the benefits obtained with antidepressants. The advantages of a mixed treatment have been proposed for depressed patients showing a partial response to a single treatment, for those with chronic depression and for patients with brief recovery periods. Thus, Bellak’s brief and urgency therapy for the treatment of depression came into being. This kind of therapy uses psychodynamic theoretical elements together with psychodynamic, supportive and cognitive techniques. It takes into account problems concerning the selfesteem regulation, the severe superego, the intra-aggression, the feeling of object loss, the feeling of object delusion, the feeling of deception, the orality, the narcissism dependence, the denial and the interferences in object relationships. Bellak’s therapy acts on the first nine points in contrast to long-term therapies which act mainly on object relationships.
Objective: To compare the effectiveness of psychotherapeutic, pharmacological, mixed and placebo treatments of mild to moderate depression.
Material and method: A prospective cohort study was designed. Volunteers were selected from outpatients attending the Centro de Salud Castro Villagrana. During 90 consecutive days, 40 subjects, men and women aged 18 to 60 years, with a diagnosis of mild to moderate depression were treated. Depression was rated according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), and the International Classification of Diseases, tenth edition (ICD-10). Severity of depression was measured with the Hamilton Scale for Severity of Depression (HAM-D). All participants signed an informed consent. Ten patients were randomly assigned to each one of the four treatment groups: Group A: fluoxetine 20 mg/day and a weekly session without psychotherapy. Group B: a weekly session of Bellak’s psychotherapy without pharmacotherapy. Group C: fluoxetine 20 mg/day and a weekly session of Bellak’s psychotherapy (mixed group). Group D: placebo and a weekly session without psychotherapy. For statistical analysis, Student’s t test was used before and after the treatment and the ANOVA for groups comparison.
Results: 62.5% were women and 37.5% males; 37.5% were single, 55% married and 7.5% divorced; 72.5% of the patients had an occupation; average age of the sample was 31.9 years; schooling average was 10.8 years. The mean baseline in HAM-D for the 40 patients was 17.27 points (minimum = 15; maximum = 19). By the third week, an important reduction in HAM-D points appeared for groups A, B and C in comparison to group D (p ‹0.001). In the seventh week, groups A and C presented a decrease in HAM-D points in comparison to group B (p ‹0.05) and with group D (p ‹0.001). In the ninth week, group C presented a bigger decrease in HAM-D points than groups A and B (p ‹0.05) and group D (p ‹0.001). By the eleventh week, there was a different reduction of HAM-D points in groups A, B and C in comparison to group D (p ‹0.001). In weeks 32 and 44, there were no differences among groups A, B and C.
Discussion: Bellak’s psychotherapy had the same therapeutic response than the use of an antidepressant, a lower response than a mixed therapy and a better response than a placebo. Still, results may be modified in the long-term by the natural development of the illness. Psychotherapies have had better results in avoiding relapses and modifying behavoir in the depression disorder. Their advantages and disadvantages are similar to those of some other psychotherapies. The use of psychotherapy in the treatment of depression is important because there are patients who do not accept an antidepressant treatment due to sociocultural factors or to a high sensibility to side effects. Considering this, we suggest carrying out more studies on the benefits of psychotherapy as an alternative for the treatment of depression in Mexico.


REFERENCES

  1. AMERICAN PSYCHIATRIC ASSOCIATION. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4a edición. APA, Washington, 1994.

  2. BELLAK L: Manual de Psicoterapia Breve, Intensiva y de Urgencia. Manual Moderno, México, 1993.

  3. BELLAK L: Manual para la Evaluación de las Funciones del Yo. Manual Moderno, México, 1994.

  4. BLEICHMAR NM: El Psicoanálisis Después de Freud, Teoría y Clínica. Elia Editores, México, 1997.

  5. CALDECOTT-HAZARD S, MORGAN DG: Clinical and biochemical aspects of depressive disorders: II Trasmitter/ receptor theories. Synapse, 9:251, 1991.

  6. CARAVEO AJ y cols.: Prevalencia de trastornos psiquiátricos en la población urbana adulta en México. Salud Mental, 19(3):14-21, 1996.

  7. CARAVEO AJ y cols.: Prevalencia en la vida de episodios depresivos y utilización de servicios de salud. Salud Mental, 20 (supl. 2):15-23, 1997.

  8. CATON W, SCHULBERG H: Epidemiology of depression in primary care. Gen Hosp Psychiatry, 14:237, 1992.

  9. D’LEARY KD: Marital therapy: a viable treatment for depression and marital discord. Am J Psychiatry, 147:183-186, 1990.

  10. DEAKIN JFW: Depression and 5HT. Int Clin Psychopharmacol, 6:23, 1991.

  11. ELKIN I y cols.: National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry, 46:971-982, 1989.

  12. FLEMING BM: Coping skill training as a component in the short-term treatment of depression. J Consult Clin Psychol, 48:652-654, 1980.

  13. HALL CS: Compendio de Psicología Freudiana. Biblioteca de Psicología Profunda. Paidos, México, 1997.

  14. HALLON SD y cols.: Cognitive therapy and pharmacotherapy for depression: singly and in combination. Arch Gen Psychiatry, 49:774-781, 1992.

  15. HAMILTON M: A rating scale for depression. J Neurology, Neurosurgery Psychiatry, 23:56-60, 1960.

  16. HEUN R, MAIER W: The distinction of bipolar II disorder from bipolar I and unipolar depression: results of a controlled family study. Acta Psychiatric Scan, 87:279, 1993.

  17. JACOBSON NS y cols.: Marital therapy as a treatment for depression. J Consult Clin Psychol, 59:547-557, 1991.

  18. KAPLAN I: Sinopsis de Psiquiatría, Ciencias de la Conducta. Psiquiatría Clínica. Séptima edición. Editorial Médica Panamericana, Madrid 1996.

  19. KLEIN DNA, MILLER GA: Depressive personality. Am J Psychiatry, 150:11, 1993.

  20. ORGANIZACION MUNDIAL DE LA SALUD, CIE-10: Décima Revisión de la Clasificación Internacional de las Enfermedades. Trastornos Mentales y del Comportamiento. Madrid, 1992.

  21. PERSONS JB: The role of psychotherapy in the treatment of depression. Arch Gen Psychiatry, 53:283-290, 1996.

  22. POST RM: Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry, 149:999, 1992.

  23. RUSH AJ, BECK AT: Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed out patients. Cognit Ther Res, 1:17-38, 1977.

  24. SHAW BF: Comparison of cognitive therapy y behaviour therapy in treatment of depression. J Consult Clin Psychol, 45:543-551, 1977.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Salud Mental. 2004;27